Search

Your search keyword '"Synaptic Vesicles pathology"' showing total 139 results

Search Constraints

Start Over You searched for: Descriptor "Synaptic Vesicles pathology" Remove constraint Descriptor: "Synaptic Vesicles pathology"
139 results on '"Synaptic Vesicles pathology"'

Search Results

51. Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease.

52. SYN2 is an autism predisposing gene: loss-of-function mutations alter synaptic vesicle cycling and axon outgrowth.

53. PRICKLE1 interaction with SYNAPSIN I reveals a role in autism spectrum disorders.

54. ATM and the epigenetics of the neuronal genome.

55. Chloroquine causes similar electroretinogram modifications, neuronal phospholipidosis and marked impairment of synaptic vesicle transport in albino and pigmented rats.

56. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease.

57. Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons.

58. FIB/SEM technology and Alzheimer's disease: three-dimensional analysis of human cortical synapses.

59. Motor endplate disease affects neuromuscular junction maturation.

60. Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy.

61. Morphologic and functional correlates of synaptic pathology in the cathepsin D knockout mouse model of congenital neuronal ceroid lipofuscinosis.

62. Activation of metabotropic GABA receptors increases the energy barrier for vesicle fusion.

63. Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype.

64. Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71.

65. Loss of synaptic vesicles from neuromuscular junctions in aged MRF4-null mice.

66. Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration.

67. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome.

68. Dysfunction of the fusion of pre-synaptic plasma membranes and synaptic vesicles caused by oxidative stress, and its prevention by vitamin E.

69. SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals.

70. Mitochondria and neonatal epileptic encephalopathies with suppression burst.

71. The nonsense-mediated decay pathway maintains synapse architecture and synaptic vesicle cycle efficacy.

72. Regenerated synapses in lamprey spinal cord are sparse and small even after functional recovery from injury.

73. Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain.

74. Bilateral effects of unilateral cochlear implantation in congenitally deaf cats.

75. Distinct FGFs promote differentiation of excitatory and inhibitory synapses.

76. Evaluation of synaptophysin as an immunohistochemical marker for equine grass sickness.

77. Reactive hypertrophy of synaptic varicosities within the hippocampus of prion-infected mice.

78. TorsinA and DYT1 dystonia: a synaptopathy?

79. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila.

80. Overexpression of Dyrk1A causes the defects in synaptic vesicle endocytosis.

81. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.

82. Synaptopathy under conditions of altered gravity: changes in synaptic vesicle fusion and glutamate release.

83. Seizures, enhanced excitation, and increased vesicle number in Lis1 mutant mice.

84. Early synaptic defects in tulp1-/- mice.

85. Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy.

86. Synaptojanin1 is required for temporal fidelity of synaptic transmission in hair cells.

87. Locomotor recovery after spinal cord lesions in the lamprey is associated with functional and ultrastructural changes below lesion sites.

88. Establishment of a novel neuroblastoma mouse model.

89. Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients.

90. Reduced synaptic vesicle density and aberrant synaptic localization caused by a splice site mutation in the Rs1h gene.

91. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.

92. Interaction of huntingtin fragments with brain membranes--clues to early dysfunction in Huntington's disease.

93. Ischemia-induced modifications in hippocampal CA1 stratum radiatum excitatory synapses.

94. Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice.

95. Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2.

96. Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study.

97. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.

98. Cytodiagnosis of central neurocytoma in intraoperative preparations.

99. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.

Catalog

Books, media, physical & digital resources